SCHEMBL15519297

SCHEMBL15519297

Cc1nc2c(Br)cccn2c(=O)c1C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.40
MAPT P10636 3/20 0.40
RECQL P46063 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
ALDH1A1 P00352 6/20 0.37
GAA P10253 2/20 0.37
HPGD P15428 2/20 0.37
LMNA P02545 1/20 0.36
GLA P06280 1/20 0.36
MPI P34949 1/20 0.36
ATP4A P20648 3/20 0.36
ATP4B P51164 3/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
NPC1 O15118 1/20 0.35
HTT P42858 1/20 0.35
PTPN2 P17706 1/20 0.35
PTPN1 P18031 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
CASP1 P29466 1/20 0.35
CASP7 P55210 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11807279 0.84 KDM4E (0.55) KDM4EMAPTRECQLNPSR1ALDH1A1
SCHEMBL7016018 0.81 ALDH1A1 (0.56) KDM4EMAPTRECQLNPSR1ALDH1A1
SCHEMBL22319118 0.80 KDM5B (0.40) KDM4EMAPTRECQLNPSR1ALDH1A1
SCHEMBL10921260 0.78 ATP4A (0.53) KDM4EMAPTALDH1A1ATP4AATP4B
SCHEMBL30037834 0.75 ATP4A (0.38) ALDH1A1ATP4AATP4BSMN1; SMN2PTPN2
SCHEMBL2818532 0.75 KDM4E (0.52) KDM4EMAPTRECQLNPSR1ALDH1A1
SCHEMBL15519561 0.72 ALDH1A1 (0.67) KDM4EMAPTALDH1A1GAALMNA
SCHEMBL11357473 0.71 KMT2A (0.56) KDM4EMAPTNPSR1ALDH1A1GAA
SCHEMBL2823188 0.70 TDP1 (0.43) MAPTALDH1A1ATP4AATP4BTDP1
SCHEMBL20579804 0.68 SMN1; SMN2 (0.78) KDM4EMAPTNPSR1ALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2708540-B1 PYRIMIDO-DIAZEPINONE COMPOUND KYOWA HAKKO KIRIN CO LTD (JP) 2018-07-25 EP disclosed
US-9453021-B2 Pyrimidodiazepinone compound KYOWA HAKKO KIRIN CO., LTD. (JP) 2016-09-27 US disclosed
US-20140171422-A1 PYRIMIDODIAZEPINONE COMPOUND KYOWA HAKKO KIRIN CO., LTD. (JP) 2014-06-19 US disclosed
EP-2708540-A1 PYRIMIDO-DIAZEPINONE COMPOUND Kyowa Hakko Kirin Co., Ltd. (JP) 2014-03-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140171422-A1 PYRIMIDODIAZEPINONE COMPOUND REN, AGTR1, KCNJ1 KDM4E 2816/4885MAPT 4569/4885RECQL 963/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.